Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Cardiol Therapeutics Inc. (CRDL)

ADC Therapeutics SA and Cardiol Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $111.8M — 1.9× the size. Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cardiol Therapeutics Inc. leads on 7 and ADC Therapeutics SA on 5.

Valuation

Metric ADCT CRDL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 n/m 2.08
P/B n/m 6.16 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.95 n/m 2.87
Earnings yield (39.76%) (26.88%) (15.94%)
Free cash flow yield (39.53%) (16.13%) 0.00%

Profitability

Metric ADCT CRDL Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 0.00% 53.51%
Operating margin (125.08%) 0.00% 0.00%
Net margin (121.77%) 0.00% (2.45%)
Free cash flow margin (127.72%) 0.00% 0.00%
Return on equity 45.35% (171.13%) (0.80%)
Return on assets (32.25%) (124.40%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADCT CRDL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% — 5.22%
EPS growth (last fiscal year) 30.86% 24.32% 42.91%
Revenue growth, 5-year CAGR 103.35% — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT CRDL Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.00 0.04
Current ratio 3.03 5.55 2.41
Net debt to EBITDA 1.22 0.62 1.01

Dividend

Metric ADCT CRDL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT CRDL Drug Manufacturers Specialty & Generic median
Market cap 209.38m 111.79m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack